NECAB3

NECAB3 (XB51/NIP1) is a Golgi-associated, calcium-binding adaptor protein that couples scaffold-protein interactions to two distinct biological outputs: amyloid precursor protein (APP) processing and hypoxia-inducible factor (HIF-1) signaling (PMID:10833507, PMID:26948053). Through its interaction with the X11-like protein X11L (APBA2), NECAB3 modulates amyloid-β generation in an isoform-specific manner: the exon-9-containing hXB51α forms a tripartite complex with X11L and APP that relieves X11L-mediated suppression of Aβ production, whereas hXB51β suppresses Aβ generation through an X11L-independent route (PMID:10833507, PMID:12780348). In cancer cells, NECAB3 binds the phosphotyrosine-binding domain of Mint3 and assembles a ternary complex with Mint3 and FIH-1 at the Golgi, promoting HIF-1 activation under normoxia and thereby enhancing glycolysis and tumourigenicity; an intact monooxygenase domain is required for this activity (PMID:26948053). This HIF-1 axis extends to a HIF-1α/RIT1 signaling cascade that drives migration and invasion in liver cancer cells, with NECAB3 acting upstream of RIT1 (PMID:37215053). NECAB3 is also a physical partner and in vivo substrate of the mitotic kinase Nek2, linking it to cell-cycle-dependent Golgi regulation (PMID:14697346).

1. 2000 High

   Established NECAB3's first functional partner and role: it was unknown what regulated X11L's control of amyloid processing, and this work showed XB51 binds X11L's N-terminus and abolishes X11L-mediated suppression of Aβ, defining NECAB3 as a modulator of APP processing.

   Evidence Yeast two-hybrid, co-IP, subcellular fractionation, and Aβ ELISA

   PMID:10833507

   Open questions at the time

   • Mechanism of non-competitive inhibition not structurally resolved
   • Physiological context of the CHAPS-insoluble perinuclear pool undefined
2. 2003 High

   Resolved how a single gene could have opposing effects on Aβ by showing two isoforms diverge: hXB51α (exon 9+) enhances Aβ via a tripartite X11L/APP complex while hXB51β suppresses Aβ X11L-independently, establishing isoform-specific regulation.

   Evidence RT-PCR isoform identification, yeast two-hybrid, co-IP, Aβ secretion assay

   PMID:12780348

   Open questions at the time

   • X11L-independent mechanism of hXB51β not identified
   • In vivo relevance to amyloid pathology untested
3. 2004 Medium

   Connected NECAB3 to cell-cycle machinery by showing it physically interacts with and is phosphorylated by the mitotic kinase Nek2 at the Golgi, raising a role in Golgi-related cell cycle processes.

   Evidence Yeast two-hybrid, co-IP, in vivo phosphorylation assay, immunofluorescence

   PMID:14697346

   Open questions at the time

   • Phosphosite(s) on NECAB3 not mapped
   • Functional consequence of Nek2 phosphorylation undefined
   • Single lab, no reciprocal confirmation
4. 2016 High

   Defined a distinct signaling function: NECAB3 binds the Mint3 PTB domain and forms a Mint3/FIH-1 ternary complex at the Golgi to drive normoxic HIF-1 activation, glycolysis, and tumourigenicity, with the monooxygenase domain shown necessary by dominant-negative mutagenesis.

   Evidence Yeast two-hybrid, co-IP, co-localization, shRNA knockdown, dominant-negative mutant, HIF-1 target assays, glycolysis and tumourigenicity assays

   PMID:26948053

   Open questions at the time

   • Catalytic activity of the monooxygenase domain not biochemically demonstrated
   • How the complex inhibits FIH-1 mechanistically unresolved
5. 2023 Medium

   Extended the HIF-1 axis to a defined downstream effector by placing NECAB3 upstream of RIT1 via HIF-1α, with RIT1 overexpression rescuing migration/invasion defects of NECAB3 knockdown in liver cancer.

   Evidence siRNA knockdown, transwell migration/invasion, Western blot, RIT1 rescue, xenograft assay

   PMID:37215053

   Open questions at the time

   • Direct molecular link from HIF-1α to RIT1 not established
   • Single lab, limited to liver cancer context

• How NECAB3's calcium-binding and monooxygenase domains mechanistically contribute to its adaptor functions, and whether its APP-modulating and HIF-1-promoting roles are coordinated, remains unresolved.
• No structural model of any NECAB3 complex
• Catalytic function of the monooxygenase domain undemonstrated
• Calcium-binding contribution to function untested